Related Experiment Videos
Case report: Crouzon syndrome with short stature
C R Feild1, A Leiber, C Toniges
1Exceptional Family Member Service, U.S. Army Hospital, Wurzburg, Federal Republic of Germany.
The American Journal of the Medical Sciences
|August 1, 1991
Summary
Children with Crouzon Syndrome may experience partial growth hormone deficiency, impacting growth. Human growth hormone replacement can accelerate growth in these patients.
Area of Science:
- Pediatric Endocrinology
- Genetics
- Growth Disorders
Background:
- Crouzon Syndrome is a genetic disorder characterized by premature fusion of skull bones.
- Craniofacial abnormalities in Crouzon Syndrome can affect overall development.
- Growth disturbances are a potential, though less commonly emphasized, complication.
Observation:
- A five-year-old boy diagnosed with Crouzon Syndrome presented with short stature and delayed bone age.
- Initial assessments indicated partial growth hormone deficiency.
Findings:
- Treatment with human growth hormone (hGH) replacement therapy resulted in accelerated physical growth.
- The patient demonstrated a positive response to hGH therapy, indicating efficacy in addressing the deficiency.
Implications:
- This case highlights the importance of comprehensive growth monitoring in children with Crouzon Syndrome.
- Pediatricians should consider evaluating for growth hormone deficiency in affected children.
- Monitoring all growth parameters, not solely head circumference, is crucial for early detection and intervention.